Sanofi (SNY) Gross Profit (2009 - 2026)
Sanofi (SNY) posted Gross Profit of $10.8 billion for Q2 2026, up 13.7% sequentially from $9.5 billion in Q1 2026, and up 23.11% YoY from $8.8 billion in Q2 2025.
Sanofi (SNY) Gross Profit (2009 - 2026) Analysis & Trends
Sanofi has reported Gross Profit for 18 years, with the latest figure at $10.8 billion in Q2 2026.
- Quarterly Gross Profit rose 23.11% year-over-year to $10.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $41.6 billion (up 26.68% YoY) and the FY2025 annual result came in at $39.2 billion, up 18.0% from the prior year.
- Gross Profit improved to $10.8 billion in Q2 2026 per SNY's latest filing, from $9.5 billion in the prior quarter.
- Over five years, Gross Profit peaked at $31.2 billion in Q4 2023 and troughed at -$8.2 billion in Q4 2025.
- A 5-year average of $10.9 billion and a median of $8.6 billion in 2023 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 188.22% in 2025, down 242.49% in 2025.
- Over 5 years, Gross Profit stood at $24.5 billion in 2022, then rose by 27.53% to $31.2 billion in 2023, then sank by 81.64% to $5.7 billion in 2024, then plunged by 242.49% to -$8.2 billion in 2025, then jumped by 232.21% to $10.8 billion in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $10.8 billion, $9.5 billion, and -$8.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.79 Bn |
| Jun 30, 2026 | 10.79 Bn |
| Mar 31, 2026 | 9.49 Bn |
| Mar 31, 2026 | 9.49 Bn |
| Dec 31, 2025 | -8.16 Bn |
| Dec 31, 2025 | -8.16 Bn |
| Sep 30, 2025 | 29.48 Bn |
| Sep 30, 2025 | 29.48 Bn |
| Jun 30, 2025 | 8.76 Bn |
| Jun 30, 2025 | 8.76 Bn |
| Mar 31, 2025 | 8.12 Bn |
| Mar 31, 2025 | 8.12 Bn |
| Dec 31, 2024 | 5.73 Bn |
| Dec 31, 2024 | 5.73 Bn |
| Sep 30, 2024 | 10.23 Bn |
| Sep 30, 2024 | 10.23 Bn |
| Jun 30, 2024 | 7.72 Bn |
| Jun 30, 2024 | 7.72 Bn |
| Mar 31, 2024 | 7.34 Bn |
| Mar 31, 2024 | 7.34 Bn |